0

Rhythm Disorders and Devices Collection
 1-20 of 617 Articles
Ideas and Opinions |  25 March 2014 ONLINE FIRST
Premarket Approval Supplement Pathway: Do We Know What We Are Getting?
Sarah Y. Zheng, AB; Rita F. Redberg, MD
Ann Intern Med. Published online 25 March 2014 doi:10.7326/M13-2931
Reviews |  21 January 2014 FREE
Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death in Subgroups: A Systematic Review
Amy Earley, BS; Rebecca Persson, BS; Ann C. Garlitski, MD; et al.
Ann Intern Med. 2014;160(2):111-121. doi:10.7326/M13-1787
Web-Only Features |  21 January 2014 FREE
The Consult Guys - Atrial Fibrillation: How Controlled is Well-Controlled?
Geno J. Merli, MD; Howard H. Weitz, MD
Ann Intern Med. 2014;160(2):CG1. doi:10.7326/G14-3001
Original Research |  3 December 2013
Atrial Ectopy as a Predictor of Incident Atrial Fibrillation: A Cohort Study
Thomas A. Dewland, MD; Eric Vittinghoff, PhD, MPH; Mala C. Mandyam, MD; et al.
Ann Intern Med. 2013;159(11):721-728. doi:10.7326/0003-4819-159-11-201312030-00004
Editorials |  3 December 2013
Ectopy and Expectations: Can We Predict Atrial Fibrillation, and Should We Try?
Daniel B. Kramer, MD; Peter J. Zimetbaum, MD
Ann Intern Med. 2013;159(11):787-788. doi:10.7326/0003-4819-159-11-201312030-00014
Original Research |  18 June 2013
Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy: A Subgroup Analysis of a Randomized Trial
Kenneth W. Mahaffey, MD; Daniel Wojdyla, MS; Graeme J. Hankey, MD; et al.
Ann Intern Med. 2013;158(12):861-868. doi:10.7326/0003-4819-158-12-201306180-00003
Original Research |  21 May 2013
Trends in Reporting Methadone-Associated Cardiac Arrhythmia, 1997–2011: An Analysis of Registry Data
David Kao, MD; Becki Bucher Bartelson, PhD; Vaishali Khatri, MPH; et al.
Ann Intern Med. 2013;158(10):735-740. doi:10.7326/0003-4819-158-10-201305210-00008
Reviews |  5 March 2013
Cognitive Impairment Associated With Atrial Fibrillation: A Meta-analysis
Shadi Kalantarian, MD, MPH; Theodore A. Stern, MD; Moussa Mansour, MD; et al.
Ann Intern Med. 2013;158(5_Part_1):338-346. doi:10.7326/0003-4819-158-5-201303050-00007
Reviews |  4 December 2012
Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism: A Systematic Review
Soheir S. Adam, MD; Jennifer R. McDuffie, PhD; Thomas L. Ortel, MD, PhD; et al.
Ann Intern Med. 2012;157(11):796-807. doi:10.7326/0003-4819-157-10-201211200-00532
Original Research |  16 October 2012
Reuse of Explanted, Resterilized Implantable Cardioverter-Defibrillators: A Cohort Study
Behzad B. Pavri, MD; Yash Lokhandwala, MBBS, DM; Gaurav V. Kulkarni, MD; et al.
Ann Intern Med. 2012;157(8):542-548. doi:10.7326/0003-4819-157-8-201210160-00004
Editorials |  16 October 2012
Reuse of Medical Devices and Global Health Equity
Paul Farmer, MD, PhD; Gene Bukhman, MD, PhD
Ann Intern Med. 2012;157(8):591-592. doi:10.7326/0003-4819-157-8-201210160-00015
Original Research |  3 July 2012
Improving the Efficiency of Advanced Life Support Training: A Randomized, Controlled Trial
Gavin D. Perkins, MD; Peter K. Kimani, PhD; Ian Bullock, PhD; et al.
Ann Intern Med. 2012;157(1):19-28. doi:10.7326/0003-4819-157-1-201207030-00005
Editorials |  3 July 2012
Advanced Life Support Training: Does Online Learning Translate to Real-World Performance?
Steven J. Yule, PhD; Ron M. Walls, MD
Ann Intern Med. 2012;157(1):69-70. doi:10.7326/0003-4819-157-1-201207030-00013
Ideas and Opinions |  3 July 2012
Dabigatran: Uncharted Waters and Potential Harms
Ryan P. Radecki, MD
Ann Intern Med. 2012;157(1):66-68. doi:10.7326/0003-4819-157-1-201207030-00467
Original Research |  7 February 2012
Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database
Derek R. MacFadden, MD; Eugene Crystal, MD; Andrew D. Krahn, MD; et al.
Ann Intern Med. 2012;156(3):195-203. doi:10.7326/0003-4819-156-3-201202070-00007
Editorials |  7 February 2012
Is Biology Destiny or Can We Optimize Care for All Patients?
Pamela S. Douglas, MD; Lesley H. Curtis, PhD
Ann Intern Med. 2012;156(3):241-242. doi:10.7326/0003-4819-156-3-201202070-00015
Original Research |  15 November 2011
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
Jonas Oldgren, MD, PhD; Marco Alings, MD, PhD; Harald Darius, MD, PhD; et al.
Ann Intern Med. 2011;155(10):660-667. doi:10.7326/0003-4819-155-10-201111150-00004
Editorials |  15 November 2011
Learning the Respective Roles of Warfarin and Dabigatran to Prevent Stroke in Patients With Nonvalvular Atrial Fibrillation
Rebecca J. Beyth, MD; C. Seth Landefeld, MD
Ann Intern Med. 2011;155(10):714-715. doi:10.7326/0003-4819-155-10-201111150-00012
Original Research |  1 November 2011
Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable
Stuart J. Connolly, MD; John W. Eikelboom, MBBS; Jennifer Ng, MSc; et al.
Ann Intern Med. 2011;155(9):579-586. doi:10.7326/0003-4819-155-9-201111010-00004
Original Research |  1 November 2011
Safety of Screening Procedures With Hand-Held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices: A Cross-sectional Analysis
Clemens Jilek, MD; Stylianos Tzeis, MD, PhD; Hrvoje Vrazic, MD, PhD; et al.
Ann Intern Med. 2011;155(9):587-592. doi:10.7326/0003-4819-155-9-201111010-00005
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)